Skip to main content

Table 1 Clinical characteristics of the patients with cirrhosis and cirrhosis plus HCC

From: AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

  Cirrhosis HCC
Number 41 50
Age (years) 54.3 ± 9.62 67.5 ± 12.02
Male:Female 28:13 40:10
ALD:NAFLD 33:08 30:20
Childs-Pugh A:B:C 22:14:05 27:18:05
Portal vein invasion NA 8
Single nodule NA 22
Two nodules NA 10
≥ 3 nodules NA 18
  1. The difference in age between HCC and cirrhosis alone patients was statistically significant (p < 0.001; Pearson Chi square test), while there was no significant difference between sex or Child-Pugh Stage in the two groups. NA – not applicable.